ZENO Zenosense Inc

About ZENO

Zenosense, Inc. engages in developing medical devices for the diagnosis of heart attack and cardiac-related illnesses. It includes the detection of the Methicillin-resistant Staphylococcus aureus. The firm uses Acute Myocardial Infarction, and MIDS Cardiac technologies. The company was founded on August 11, 2008 and is headquartered in New Haven, CT.
50

Neutral Sentiment

How do you feel about ZENO?

Advertisement|Remove ads.